Energia i regulacje · 03/07/2000

Mallinckrodt to Modify OxyContin License Following U.S. Government Order

Mallinckrodt, Inc., a pharmaceutical company based in St Louis, Missouri, has received a confirmatory order from the U.S. government to modify its license, following a previous agreement. The order is related to the company's opioid painkiller, OxyContin.